ÍøºìºÚÁÏ

Skip to main content
(352) 273-9120

Biljana Horn, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Biljana Horn
(352) 273-9120 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Hematopoietic Stem Cell Transplantation , 34 publications
  • Graft vs Host Disease , 12 publications
  • Transplantation Conditioning , 11 publications
  • Transplantation, Homologous , 10 publications

Research activity

60 publications

1,620 citations

Why is this important?

Active clinical trials

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
1 Year - 70 Years
Sexes
All
Conditioning SCID Infants Diagnosed Early (CSIDE)

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
0 Years - 2 Years
Sexes
All

My publications

60 publications

2013

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.

Bone marrow transplantation

•

2013

Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.

The Journal of allergy and clinical immunology

•

2012

Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.

Journal of immunotherapy (Hagerstown, Md. : 1997)

•

2012

Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

•

2012

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis.

Bone marrow transplantation

•